We also examined the distribution of GFV (in milliliters per kilogram) by age group. Among the 1- to 5-year-old and the 13-years-and-older age groups, the GFV was significantly lower for those who did not receive oral contrast than it was for those who did (medians 0.19 vs. 0.42 mL/kg, P = 0.0344 for the 1- to 5-year-old age group; medians 0.06 vs. 4.53, P = 0.0043 for the 13-and-older age group). There was no significant difference in GFV between those who did and those who did not receive oral contrast among the less-than-1-year-olds and the 6- to 12-year-olds.
Of the 365 patients who received oral contrast, 91 (25%) had zero GFV in comparison with 15 (32%) of the 47 who did not receive oral contrast (Fig. 1). The difference in incidence of zero volume between the groups was not significant (χ2 = 1.06; P = 0.3026).
There were 189 patients who had GFV that exceeded 0.4 mL/kg. Of the 365 patients who received oral contrast, 178 patients (49%) had GFV >0.4 mL/kg in comparison with 11 (23%) of the 47 in the IV contrast group (χ2 = 10.7874, P = 0.0010).
We also examined the relationship between volume of ECM administered and residual volume at 1 hour after ingestion. The data are shown as fraction of administered volume remaining as a function of the fraction of patients (Table 4). This enables one to estimate the GFV in milliliters per kilogram 1 hour after contrast administration if the volume of contrast given in milliliters per kilogram is known.
The distribution of contrast within the alimentary canal of the 365 children who received oral contrast was not uniform. Contrast was present in the small intestine in 328 (90%) and in the large intestine in 285 (78%) of the 365 patients studied. Contrast opacified both small and large intestines in 271 (74%).
The range for presenting pathology for patients with large residual GFV (outliers) is shown in Table 5. We also examined the presence or absence of ascites in these patients. Of the 34 outliers, 5 had ascites, giving an incidence of 14.71%. Of the 378 nonoutliers, only 22 had ascites, giving an incidence of 5.82%. Even though it looks like there is a difference of 14.71% versus 5.82%, we do not have enough evidence to say that outliers had a higher incidence of ascites because the Fisher's exact test has a P value = 0.0605.
The majority of patients who received ECM and had GA (207) were induced with propofol and anesthesia maintained with sevoflurane. The airway support for these patients was 99 (48%) ETT, 36 (17%) LMA, and 6 (3%) tracheotomy. For the remaining subjects, intermittent spontaneous mask ventilation with or without an oral airway was used. Rapid sequence induction was given to 65 patients among the 99 patients who had an ETT.
The most frequently used sedatives for patients who had sedation (178) were IV pentobarbital 154 (87%), dexmedetomidine 11 (6%), or a combination of midazolam, fentanyl with dexmedetomidine, and pentobarbital in 25 (14%). None of these patients required any airway support during imaging.
There was no evidence of pulmonary aspiration in any patient. Among patients who had GA the following complications occurred: one incident of vomiting after awake extubation (GFV was zero), and one incident of vomiting after the LMA was removed at deep plane of anesthesia (GFV was 7 mL/kg). Four patients had oxygen desaturation (<94%) in the postanesthesia care unit. All of these desaturations were related to airway obstruction, which improved with head positioning and oxygen administration. One patient had laryngospasm that was terminated by positive pressure ventilation during induction. Among patients who had deep sedation, 1 patient with a history of reactive airway had oxygen desaturation in the postanesthesia care unit and was treated successfully with albuterol. This patient was sedated with pentobarbital. None of the patients who had IV contrast had any complication related to contrast administration.
The practice of administering ECM by mouth or enteric tube before sedating a child for CT has been a routine procedure at our institution and at most large pediatric institutions in the United States for decades.1,2 This practice is now being questioned on the basis of safety-related concerns because it violates fasting guidelines that are used to reduce the risk of rare pulmonary aspiration of gastric contents.7 Anesthesiologists are asked to accommodate the 1 hour prior ECM administration and design an appropriate anesthetic plan to obtain an accurate study. The use of ECM in close proximity to a GA creates a conflict for the anesthesia provider because the study cannot be cancelled because of a violation of fasting guidelines.
There are several points that are important in balancing the concerns of the radiologist in terms of obtaining a diagnostically accurate study with those of the anesthesiologist caring for the patient. The data in this study show that the timing of ECM administration is appropriate from a diagnostic imaging standpoint. Seventy-four percent of patients in which this protocol was used had opacification of the small and large intestines. Children often have a very rapid small intestine transit time. Waiting several hours after administration of contrast will often result in inadequate opacification of the small intestine.4 Small intestine transit time can be as fast as 15 minutes and on average is 1 hour and 24 minutes.3 In 83% of cases, small intestine transit time is <2 hours.3 Inadequate opacification of the small intestine can lead to diagnostic confusion between small intestine loops and fluid collections or masses.4
In 1974, Roberts and Shirley published a report regarding acid aspiration during cesarean delivery.5 The investigators reported that 0.4 mL/kg is the maximum acid aspirate that does not produce significant changes in the lungs. Numerous subsequent studies considered this value of 0.4 mL/kg as a risk factor for aspiration in humans. In 1988, however, Raidoo et al.6 found that in a primate model, the maximum acid aspirate volume that will not cause damage to the lungs is 0.8 mL/kg. Although increased gastric contents theoretically increase the risk of aspiration pneumonia, there is no known GFV that places a particular patient at clinically relevant risk or eliminates all the risk.8 GFV has been used as a surrogate marker for pulmonary aspiration risk in studies evaluating fasting protocol safety.9–11 These studies relied on assuring small preoperative GFV when clear liquids were ingested up to 2 hours before surgery.
Eight studies with approximately 1000 children from numerous centers investigated the ingestion of clear fluids by healthy children before elective surgery. A variety of clear fluids, of variable volumes (as much as 65 mL/kg), were ingested 2 to 3 hours before surgery, and the range of GFV was between 0.24 ± 0.31 and 0.57 ± 0.38 mL/kg.9,10,12–17 Cook-Sather et al. recently examined body mass index percentile and fasting duration effect on GFV and gastric fluid pH in children 2 to 12 years old and concluded that overweight/obese children may be allowed clear liquids 2 hours before surgery as GFV (ideal body weight) averages 1 mL/kg regardless of body mass index and fasting interval.18 Splinter et al. showed that in the same age group (2 to 12 years old) after a prolonged fast (mean fast of 14 hours), GFV was 0.39 · 0.37 mL/kg, and after unlimited clear fluids up to 3 hours before surgery, GFV was 0.34 · 0.28 mL/kg.14 Even in the fasting state, it is expected that one will find some fluid in the stomach, given ongoing salivary (1 mL/kg/h) and gastric (0.6 mL/kg/h) secretions.19 It is worth noting that although average GFV was demonstrably small in most of the fasting patients, some patients had larger residual GFV even when they followed the traditional fasting guidelines.
Previous studies measured estimated GFV by using blind aspiration through multiorificed catheters while the patient was placed in the supine, left, and right decubitus positions.11,18 With this method, 96%–97% of GFV is recovered.11,20 In our study we took a different approach in measuring the GFV by using the CT images as was previously described. Using the CT images to compute GFV, we found that the mean value for GFV was 2.10 ± 3.49 mL/kg. The median value for the same measurement was 0.38 mL/kg with the 25th percentile at 0.01 mL/kg and the 75th percentile at 2.99 mL/kg (Fig. 2). The large difference between the mean and median for the oral contrast group suggests that the distribution of GFV is very nonnormal, which was confirmed by performing the Shapiro–Wilk test (z = 10.35, P < 0.00, 001).
For the patients included in this study, the volume of diluted contrast administered was dependent on the age of the patient; the same volume is given to patients at both ends of an age range. The patients at the low end of the age range would get a larger volume on a per kilogram basis than would the patients at the upper end of the age range and thus have larger GFV. This practice causes a discontinuous relationship between age and residual GFV. As a result of this study, the contrast administration protocol is currently being revised to administer the contrast on a weight basis to reduce the probability of patients with large GFV.
It is difficult to compare our results with previous studies because we measured the GFV after 1 hour of fasting. Previous studies did premedicate with oral acetaminophen or midazolam, and these drugs are known to be associated with increased GFV. Our approach to measuring the GFV, which is standard and accepted technique for volume measurement in the radiology literature,21 was different from that in previous studies, which measured estimated GFV by using blind aspiration of the gastric contents. Lastly, the patient populations in the cited studies were ASA I or II, and they presented for elective surgery, which requires tracheal intubation. Most of our patients have coexisting diseases that might affect the gastrointestinal motility, but we did not find any correlation between ASA status and GFV. We were also unable to demonstrate increased residual GFV with specific coexisting disease.
A death related to the aspiration of contrast material has been reported in an adult who was undergoing CT.22 In addition several cases of aspiration from contrast material leading to adverse affects in children who underwent CT have been well documented.23,24 These described cases have occurred in patients who were being imaged for trauma23,24 and spurred much debate concerning the safety of administering ECM for the CT examination of trauma patients. The safety of administering ECM for CT before sedation has been studied. Ziegler et al. examined the safety records of 367 patients who received oral contrast material before sedation for abdominal CT. Chloral hydrate was given to 30 patients and pentobarbital to 337. The results showed that in 4 cases (1%), vomiting occurred as the patient was awakening from sedation; however, there were no associated events. All 4 patients had been sedated with pentobarbital.25
The multicenter Pediatric Sedation Research Consortium, which collected data on 49,836 propofol sedations in children, showed that vomiting occurred 49 times (0.1%) and aspiration occurred 4 times during these 10,000 sedation/anesthesia encounters (0.04%).26 A retrospective study by Sanborn et al. of 16,467 sedations during imaging procedures in children using chloral hydrate, midazolam, fentanyl, or pentobarbital found 70 (0.4%) respiratory incidents that included aspiration in 2 patients (aspiration incidence of 0.012%).27 The low incidence of aspiration pneumonia with sedation and anesthesia might be attributed to the fact that the stomach is a very distensible organ that accommodates large amount of fluids before the resting intragastric pressure increases.28 Gastric pressure must exceed the barrier pressure of the lower esophageal sphincter for regurgitation to occur. The barrier pressure of the lower esophageal sphincter does not appear to be as easily overcome under GA as is generally believed.28
The administration of an oral contrast is generally accepted as useful in the CT evaluation of the abdomen, especially in children, who lack the inherent internal contrast. There is, however, debate over whether CT examinations can be performed without oral contrast. When contrast is to be administered, there is no uniform practice as to the time between contrast administration and the start of the CT examination.29–31 Consequently, there is likely to be considerable variation in sedation/anesthesia practices and airway management. This variation was shown in a national survey developed and conducted by radiologists in 1988 to document the current practice for sedating children for CT at that time.2 Twenty percent of hospitals (16% of the caseload) claimed that all of their abdominal CT studies were performed on sedated patients who had been given ECM. On average, 68% of all CT studies involved children who had been sedated and given ECM; in 47% of cases the radiologist was responsible for the sedation, in 37% the primary care physician, and in only 3% was the anesthesiologist responsible. Most responders stated that the time was <1 hour (mean for all hospitals was 39 minutes). Use of intubation during CT with oral ECM was rare. Orally administered chloral hydrate was the most frequently used first-line drug for sedation in most types of CT studies.2
Limitations of our report include its retrospective nature and small sample size. We relied on chart review to detect evidence of aspiration. This procedure relies on the anesthesia provider correctly documenting all events; if a significant aspiration event had occurred, it would have been picked up as an unanticipated admission.
In conclusion, children who received EMC up to 1 hour before anesthesia/sedation had larger GVF than did those who did not receive ECM (P = 0.0049). The residual GFV exceeded 0.4 mL/kg in 49% of these patients. However, there was no evidence of increased complications in this study group. The data sample is small in relation to the reported incidence of aspiration in the literature. Therefore, we cannot make any firm recommendation on the safety of a technique for anesthesia/sedation for patients who receive ECM 1 hour before their CT exams.
1. Frush DP, Donnelly LF. Helical CT in children: technical considerations and body applications. Radiology 1998;209: 37–48
2. Keeter S, Benator RM, Weinberg SM, Hartenberg MA. Sedation in pediatric CT: national survey of current practice. Radiology 1990;175:745–52
3. Kim SK. Small intestine transit time in the normal small bowel study. Am J Roentgenol Radium Ther Nucl Med 1968;104:522–4
4. Kaufman RA. Technical aspects of abdominal CT in infants and children. Am J Roentgenol 1989;153:549–54
5. Roberts RB, Shirley MA. Reducing the risk of acid aspiration during cesarean section. Anesth Analg 1974;53:859–68
6. Raidoo DM, Marszalek A, Brock-Utne JG. Acid aspiration in primates (a surprising experimental result). Anaesth Intens Care 1988;16:375–6
7. Practice guidelines for preoperative fasting and the use of pharmacologic agents to reduce the risk of pulmonary aspiration: application to healthy patients undergoing elective procedures: a report by the American Society of Anesthesiologist Task Force on Preoperative Fasting. Anesthesiology 1999;90:896–905
8. Splinter WM, Schreiner MS. Preoperative fasting in children. Anesth Analg 1999;89:80–9
9. Splinter WM, Stewart JA, Muir JG. Large volumes of apple juice preoperatively do not affect gastric pH and volume in children. Can J Anaesth 1990;37:36–9
10. Schreiner MS, Triebwasser A, Keon TP. Ingestion of liquids compared with preoperative fasting in pediatric outpatients. Anesthesiology 1990;72:593–7
11. Cook-Sather SD, Liacouras CA, Previte JP, Markakis DA, Schreiner MS. Gastric fluid measurement by blind aspiration in paediatric patients: a gastroscopic evaluation. Can J Anaesth 1997;44:168–72
12. Splinter WM, Stewart JA, Muir JG. The effect of preoperative apple juice on gastric contents, thirst, and hunger in children. Can J Anaesth 1989;36:55–8
13. Sandhar BK, Goresky GV, Maltby JR, Shaffer EA. Effect of oral liquids and ranitidine on gastric fluid volume and pH in children undergoing outpatient surgery. Anesthesiology 1989;71:327–30
14. Splinter WM, Schaefer JD, Zunder IH. Clear fluids three hours before surgery do not affect the gastric fluid contents of children. Can J Anaesth 1990;37:498–501
15. Crawford M, Lerman J, Christensen S, Farrow-Gillespie A. Effects of duration of fasting on gastric fluid pH and volume in healthy children. Anesth Analg 1990;71:400–3
16. Miller BR, Tharp JA, Issacs WB. Gastric residual volume in infants and children following a 3-hour fast. J Clin Anesth 1990;2:301–5
17. Splinter WM, Schaefer JD. Unlimited clear fluid ingestion two hours before surgery in children does not affect volume or pH of stomach contents. Anaesth Intens Care 1990;18:522–6
18. Cook-Sather SD, Gallagher PR, Kruge LE, Beus JM, Ciampa BP, Welch KC, Shah-Hosseini S, Choi JS, Pachikara R, Minger K, Litman RS, Schreiner MS. Overweight/obesity and gastric fluid characteristics in pediatric day surgery: implications for fasting guidelines and pulmonary aspiration risk. Anesth Analg 2009;109:727–36
19. Nordgren B. The rate of secretion and electrolyte content of normal gastric juice. Acta Physiol Scand Suppl 1963;58:1–83
20. Cook-Sather SD, Tulloch HV, Liacouras CA, Schreiner MS. Gastric fluid volume in infants for pyloromyotomy. Can J Anaesth 1997;44:278–83
21. Donnelly LF, O'Brien KJ, Dardzinski BJ, Poe SA, Bean JA, Holland SK, Daniels SR. Using a phantom to compare MR techniques for determining the ratio of intraabdominal to subcutaneous adipose tissue. Am J Roentgenol 2003;180:993–8
22. Trulzsch DV, Penmetsa A, Karim A, Evans DA. Gastrografin-induced aspiration pneumonia: a lethal complication of computed tomography. South Med J 1992;85:1255–6
23. Donnelly LF, Frush DP, Frush KS. Aspirated contrast material contributing to respiratory arrest in a pediatric trauma patient. Am J Roentgenol 1998;171:471–3
24. Lim-Dunham JE, Narra J, Benya EC, Donaldson JS. Aspiration after administration of oral contrast material in children undergoing abdominal CT for trauma. Am J Roentgenol 1997;169:1015–8
25. Ziegler MA, Fricke BL, Donnelly LF. Is administration of enteric contrast material safe before abdominal CT in children who require sedation? Experience with chloral hydrate and pentobarbital. Am J Roentgenol 2003;180:13–5
26. Cravero JP, Beach ML, Blike GT, Gallagher SM, Hertzog JH. The incidence and nature of adverse events during pediatric sedation/anesthesia with propofol for procedures outside the operating room: a report from the Pediatric Sedation Research Consortium. Anesth Analg 2009;108:795–804
27. Sanborn PA, Michna E, Zurakowski D, Burrows PE, Fontaine PJ, Connor L, Mason KP. Adverse cardiovascular and respiratory events during sedation of pediatric patients for imaging examinations. Radiology 2005;237:288–94
28. Jones MJ, Mitchell RW, Hindocha N. Effect of increased intra-abdominal pressure during laparoscopy on the lower esophageal sphincter. Anesth Analg 1989;68:63–5
29. Donnelly LF. Commentary: oral contrast medium administration for abdominal CT—reevaluating the benefits and disadvantages in the pediatric patient. Pediatr Radiol 1997;27:770–2
30. Clancy TV, Ragozzino MW, Ramshaw D, Churchill MP, Covington DL, Maxwell JG. Oral contrast is not necessary in the evaluation of blunt abdominal trauma by computed tomography. Am J Surg 1993;166:680–4
© 2010 International Anesthesia Research Society
31. Harieaswar S, Rajesh A, Griffin Y, Tyagi R, Morgan B. Routine use of positive oral contrast material is not required for oncology patients undergoing follow-up multidetector CT. Radiology 2009;250:246–53